您的位置: 首页 > 农业专利 > 详情页

СПОСОБ СИНУС-ЛИФТИНГА ПРИ ДЕНТАЛЬНОЙ ИМПЛАНТАЦИИ
专利权人:
RESHETNIKOV ALEKSEJ PETROVICH
发明人:
RESHETNIKOV ALEKSEJ PETROVICH,Решетников Алексей Петрович,URAKOV ALEKSANDR LIVIEVICH,Ураков Александр Ливиевич,NIKITJUK DMITRIJ BORISOVICH,Никитюк Дмитрий Борисович
申请号:
RU2014132778/14
公开号:
RU0002563090C1
申请日:
2014.08.08
申请国别(地区):
RU
年份:
2015
代理人:
摘要:
FIELD: medicine.SUBSTANCE: before and throughout a surgical intervention, a drug exposure is used by introducing the patient into drug sedation and controlled hypotension to this effect, a patients systemic blood pressure and body weight are measured an anxiolytic is chosen an anxiolytic dose is specified taking into account the measured blood the anxiolytic is administered with controlling the psychoemotional status and blood pressure through the sedation and the hypotension. An X-ray diagnosis represents an infrared thermography to this effect, an operative part of the face is left exposed to inspection and inspected continuously and simultaneously with the thermography in the infrared tissue emission spectrum by means of a thermal camera within the range from +26 to +36°C. The thermal camera is mounted opposite a surface of interest in a position to display a colour picture on its monitor and to measure thereby temperatures of the facial skin, mucous membrane, wound surface, surgical instruments, liquids and osteoplastic materials adjoining the tissues within the wound a blood supply and homeostasis intervention level is stated safe if observing the patients body temperature and local tissue temperature falling within the normal range if the parameters remain constant, a sinus elevation operation is performed. If observing the onset of general hyperthermia, a pyrogenic reaction is stated to start, and the patients body surface is blown with an air flow of room temperature until the body temperature normalises if the hyperthermia appears to persist, a hypothermic agent is injected. Observing general hypothermia enables stating hypothermic syndrome to start the latter is prevented by intravenous administration of 10% calcium chloride in an average therapeutic dose drinking water 500 ml at temperature 42°C is introduced into the stomach that is combined with laying the patients body with warming bottles. If the region of interest shows the onset of local hyperthermi
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充